Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gastrointestinal Neoplasms × Dietary Supplements × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5 Malnutrition 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Colonic Neoplasms 2 Wilms Tumor 1 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Prostatic Intraepithelial Neoplasia 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Mucositis 1 Motor Activity 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Inflammatory Bowel Diseases 1 Hepatitis C, Chronic 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Esophagitis 1 Duodenal Neoplasms 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Oxaliplatin 11 Fluorouracil 10 Surveys and Questionnaires 8 Leucovorin 8 Cisplatin 8 Capecitabine 8 Irinotecan 7 Bevacizumab 6 Standard of Care 5 Gemcitabine 5 Drug Therapy 4 S 1 (combination) 3 Radiotherapy 3 Interviews as Topic 3 Educational Status 3 Cyclophosphamide 3 trebananib 2 tivozanib 2 pembrolizumab 2 Taxes 2 Remote Patient Monitoring 2 Pemetrexed 2 Panitumumab 2 Ocoxin 2 Nivolumab 2 N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2 Mitomycin 2 Mass Screening 2 MLN 8237 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03445260 2021-09-02

PROGRESS

Hamilton Health Sciences Corporation

Phase NA Completed

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡